A Spike-Accum bioconjugate protein vaccine confers potent SARS-CoV-2-specific immunity
Simon Beaudoin, Mark A. Hancock, Jean Pierre Bikorimana, Nathanael A. Caveney et al.
Journal
iScience
Topics
SARS-CoV-2 and COVID-19 Research
article
A Spike-Accum bioconjugate protein vaccine confers potent SARS-CoV-2-specific immunity
Simon Beaudoin, Mark A. Hancock, Jean Pierre Bikorimana, Nathanael A. Caveney, Moutih Rafei, Sébastien Talbot, Glenn Hamonic, Gabrielle A. Mandl, Darryl Falzarano, Marina P. Gonçalves, Mingmin Liao, Daniela Stanga, Jamilah Abusarah, John A. Capobianco, Nehmé El-Hachem, Roudy Farah, Qiang Liu